In 2012, The Joint Commission's tobacco cessation performance measure set took effect, encouraging hospitals to improve their efforts to convince patients to stop smoking. Used in the accreditor's ORYX performance measurement program, the measures are part of an industrywide...
One of the duodenoscope manufacturers at the center of a series of infectious outbreaks dating back to 2012 has announced plans to recall its current model and replace it with a new FDA-approved design.
Briefings on Accreditation & Quality - Volume 26, Issue 3
ECRI Institute has revealed its top 10 list of health technology hazards for 2016, and for those of us working in patient safety and quality, few if any should come as a surprise.
Briefings on Accreditation & Quality - Volume 26, Issue 3
A good job is its own reward, but that doesn't mean recognition isn't appreciated. Last year, 1,043 hospitals (31.5% of those analyzed) were recognized by The Joint Commission's Top Performer on Key Quality Measures® program. Inclusion on the top performers' list is a huge...
How prepared are you for the Joint Commission’s new Patient Safety Systems (PSS) chapter? The most recent PSS chapter came into effect on January 2015 and the Joint Commission will expect you to be up-to-date when they come around for a survey.
On February 19, the Food and Drug Administration (FDA) announced that reprocessing instructions for Pentax duodenoscopes had been validated and approved by the agency.
To find out what physicians think of the prescription problem and how to fix it, the American Medical Association conducted a national survey on the issue.
